![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 21, 18130-18138, May 25, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The c-Abl protein tyrosine kinase is activated by
certain DNA-damaging agents and regulates induction of the
stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK). The
hematopoietic progenitor kinase 1 (HPK1) has also been shown to act
upstream to the SAPK/JNK signaling pathway. We report here that
exposure of hematopoietic Jurkat T cells to genotoxic agents is
associated with activation of HPK1. The results demonstrate that
exposure of Jurkat cells to DNA-damaging agents is associated with
translocation of active c-Abl from nuclei to cytoplasm and binding of
c-Abl to HPK1. Our findings also demonstrate that c-Abl phosphorylates HPK1 in cytoplasm and stimulates HPK1 activity. The functional significance of the c-Abl-HPK1 interaction is supported by the demonstration that this complex regulates SAPK/JNK activation. Overexpression of c-Abl(K-R) inhibits HPK1-induced activation of
SAPK/JNK. Conversely, the dominant negative mutant of HPK1 blocks
c-Abl-mediated induction of SAPK/JNK. These findings indicate that
activation of HPK1 and formation of HPK1/c-Abl complexes are
functionally important in the stress response of hematopoietic cells to genotoxic agents.
Interaction of Hematopoietic Progenitor Kinase 1 and c-Abl
Tyrosine Kinase in Response to Genotoxic Stress*
,
,
,
, and
**
Department of Adult Oncology, Dana-Farber
Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, § Diabetes Research Laboratory, Department of Molecular
Biology, Massachusetts General Hospital, Harvard Medical School,
Boston, Massachusetts 02114,
Department of Radiation and
Cellular Oncology, University of Chicago, Chicago, Illinois 60637, and
¶ Department of Immunology, Baylor College of Medicine, Houston,
Texas 77030
*
This work was supported by United States Public Health
Service Grants CA75216 (to S. K.) and CA 55241 and CA 29431 (to
D. K.) awarded by the National Cancer Institute, Department of Health and Human Services and by Grants AI 8738649 and AI 42532 (to T.-H. T.)
awarded by the National Institute of Allergy and Infectious Diseases,
Department of Health and Human Services.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
G. Zhou, J. S. Boomer, and T.-H. Tan Protein Phosphatase 4 Is a Positive Regulator of Hematopoietic Progenitor Kinase 1 J. Biol. Chem., November 19, 2004; 279(47): 49551 - 49561. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ling, C. F. Meyer, L. P. Redmond, J.-W. Shui, B. Davis, R. R. Rich, M. C.-T. Hu, R. L. Wange, and T.-H. Tan Involvement of Hematopoietic Progenitor Kinase 1 in T Cell Receptor Signaling J. Biol. Chem., May 25, 2001; 276(22): 18908 - 18914. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |